This study examined whether NF-κB activation and NF-κB-dependent antiviral signaling contributes to resistance to VSV infection in the PC3 cell line, derived from an aggressive metastatic prostate cancer (PrCa) tumor. Here, NFKB1 is linked to metastatic prostate carcinoma.